Mabqi

Mabqi to Connect with the Global Scientific Community at Major Q2 2026 Events

 

Mabqi maintains a strong presence at major global conferences in 2026, showcasing recent advances in antibody discovery through presentations and posters.

📍 Where to meet us:

AACR Annual Meeting – San Diego, USA | April 17–22
Johanna Marines will present a poster on updated preclinical results for MQI-201.
The AACR Annual Meeting is one of the world’s leading cancer research conferences, bringing together scientists, clinicians, and industry leaders to share the latest advances in oncology.

BIO€QUITY Europe – Prague, CZ | May 4–6
Sylvain Yon will attend BIO€QUITY to meet partners and investors and discuss our programs and development opportunities.
BIO€QUITY Europe is a premier event connecting innovative biotech companies with international investors and strategic partners.

Antibody Engineering & Therapeutics Europe – Basel, CH | May 27–29
Anne Chevrel will give a talk on our pH-sensitive ADC in hemato-oncology currently in preclinical stage.
This international conference brings together experts in antibody therapeutics to discuss the latest scientific and technological advances in antibody engineering and biologics development.

BIO International Convention – San Diego, USA | June 22–25
Sylvain Yon, CEO will be in San Diego to build valuable connections and explore new partnership opportunities. We are also proud to be part of the French Pavilion and engage with the global biopharma community.
BIO International Convention is the largest global event dedicated to biotechnology, gathering companies, investors, institutions, and industry leaders from across the life sciences ecosystem.

Antibody Industrial Symposium – Montpellier, France | June 30 – July 1
Meet the Mabqi team – Booth #30 – to discover our latest innovations in antibody discovery and maturation know-how and capabilities. We will also share updates on our lead candidates through posters and talks.
The Antibody Industrial Symposium is a leading European congress where scientists, clinicians, and industry experts discuss advances and challenges in antibody and biomedicine development, from early research to clinical applications.

🔗 Attending one of these? Let’s connect here